Verified

GMP Pharma Formulation Manufacturing Unit for Sale

Roorkee, Uttarakhand, India

Updated

Pharmaceutical Industry

Asking Price
25 Crs

Category
Pharmaceutical Industry

Turnover
26.6 Crs

Sub Category
Formulation

Legal Entity
Private Limited

Business Listed By
Representative

For sale: GMP-approved Pharma Formulation Manufacturing Plant in Uttarakhand, spanning 1.3 acre with G+2 RCC construction. This operational facility offers a diverse range of pharmaceutical sections—Tablet, Capsule, Syrup, Dry Syrup, Liquid, Liquid Injection, Dry Injection, Lotion, Ophthalmic, and Bolus—backed by product approvals for over 2000 formulations. The plant is Non-beta. There are two sets of machines for tablets, capsules and Syrups. The plant was running until April 2023 and was purely doing contract manufacturing. The plant's strategic location ensures easy market access. An attractive proposition for pharmaceutical entrepreneurs and companies seeking a well-established, compliant manufacturing unit. Explore this opportunity to acquire a versatile asset poised for success in the dynamic pharmaceutical landscape.

Year of Establishment

2005

No. of Employees

20

Current Status of Business

Others (Minimal Operations with Bank Dues)

Business Relocatable

No

Property Type

Owned

Property Value

14 Crs

Property Classification

Industrial

Describe Property

Land Area approx 1.3 acre. Multiple buildings of G+2. Entire property in good condition. Major portion can be converted to WHO.

Competition / Market

Huge Market of 3rd Party Pharma Formulation Manufacturing. Competitive advantage of Liquid & Dry Injection manufacturing and over 2000 product approvals.

Products & Services

Third Party Manufacturing of Tablet, Capsule, Syrup, Dry Syrup, Liquid, Liquid Injection, Dry Injection, Lotion, Ophthalmic, and Bolus. Over 2000 product approvals.

Growth Potential

$130Bn size of Indian Pharma Market with more than 10% CAGR. Immense Potential for 3rd Party Manufacturing in Pvt Sector, Govt, Exports etc.

Financial Details

EBITDA 1.1 Crs

PAT N.A

Debt 21.5 Crs

Reason For Sale

Lack of Management Bandwidth/Succession & Shifting base to another location

Business Documents

Teaser/Information Memorandum

Valuation Report

Financials

Determine-the-value-of-your-business-with-businessdeals

Connect With Us For a Confidential Discussion

  • Business Acquisition
  • Sell Your Business
  • Business Growth
  • Fundraising
You cannot save your own listing